TrialDiabetes, obesity & metabolism2017

Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension.

Sang-Mo Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.